Kazia Therapeutics KZIA
NASDAQ KZIA
$6.62 -0.33 (-4.75%)
At close: Nov 13, 2026 · 4:00 PM EST

Kazia Therapeutics (KZIA) Research & Development (2009 - 2013)

Updated

Kazia Therapeutics (KZIA) reported Research & Development of $4.75 million for FY2025 (year ended Jun 30, 2025).

Analysis

Kazia Therapeutics (KZIA) Research & Development (2009 - 2013) Analysis & Trends

Dating back to FY2009, Kazia Therapeutics' Research & Development record includes 17 fiscal years.

  • Research & Development has a five-year compound annual growth rate of -6.3% (FY2020 to FY2025).
  • The FY2025 figure ranks as the lowest annual Research & Development since FY2019.
  • According to Business Quant data, Research & Development came in at $11.47 million in FY2024 (+10.9%), $10.34 million in FY2023 (-26.2%), $14.02 million in FY2022 (+28.3%) and $10.93 million in FY2021 (+66.6%).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn 4.25 Bn
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn 4.65 Bn
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn 2.57 Bn
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn 4.54 Bn
5 Novartis Ag 306.35 Bn 279.93 Bn - -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn 3.89 Bn
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn 2.11 Bn
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn 1.61 Bn
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn 3.02 Bn
10 Kazia Therapeutics 10.72 Mn -41.65 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Aug 30, 2013 2.11 Mn
Dec 31, 2012 4.73 Mn
Dec 31, 2011 111,215.53
Dec 31, 2010 1.60 Mn
Dec 31, 2009 1.28 Mn
API Access

Kazia Therapeutics Research & Development API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=research-and-development&ticker=KZIA&period=max&api_key=YOUR_API_KEY